Medical Devices & Equipment Company

Sonivate Medical, Inc.


Funding Goal $1,500,000
Funding Raised So Far $1,500,000
Funding Commitments $0
Funding Remaining $0
Funding Type Common Equity
Pre-Money Valuation
Investor Ownership
Interest / Dividend
Previous Funding

Company Overview

Sonivate Medical, Inc. (SMI) designs, develops, and manufactures innovative ultrasound technology. The company's technology opens new markets for ultrasound by extending its use into new classes of procedures and new clinical settings.

The SonicEye™, SMI's first product, is a high-performance, fingertip-mounted ultrasound probe that combines ultrasound imaging with simultaneous tactile feedback, while leaving both hands free to do work. Although it is simple in concept, the finger-worn transducer is a disruptive technology. Ultrasound is inherently low cost, portable, and safe, but adoption has been hindered because current transducers are awkward to use for procedures and are challenging to learn how to use. The SMI finger-worn transducer addresses these limitations. It allows hands-free use for procedures, and it is intuitive to use and learn how to use because it leverages what the body already knows -- how to use the hands.

lock icon

Invest in Company

Sign up or log in now to unlock profile details and access financials, company documents, and invest in companies.

Business Summary

Company Age
Prior Year Revenue
Current Year Revenue
Next Year Revenue


SonicEye™ GP

High-frequency, high-resolution, finger-worn ultrasound transducer designed for ultrasound-assisted procedures including vascular access, biopsy, needle aspirations, and surgery.

SonicEye™ TA

Medium-resolution, finger-worn transducer suited for general imaging and trauma assessment, including the FAST exam.

SonicEye™ Wearable System

Low-cost, wearable, wireless ultrasound system


David Starr
Chief Executive Officer
David S......

Mr. S...... has over 30 years of marketing and operations experience with medical and consumer devices. Mr. S...... was part of the original DeskJet printer introduction team that presided over rapid growth from $200M to over $3B in five years by pioneering a new category. At HP Medical he developed the Defibrillator strategy that led to tremendous market growth outside the hospital. He has held senior management positions at Inovise Medical (co-founder) and Hewlett-Packard (both medical and printers). BA, Cum Laude, Pomona College. MBA, University of Chicago.

Ronald W. Schutz MD
Chief Physician/Medical Officer
Ronald W......

Dr. is a board certified cardiologist and Fellow of the American College of Cardiology with nearly 30 years experience in cardiac ultrasound. In 1982 he founded Heart Sounds, Inc., a leading echocardiography service provider to hospitals and clinics and remains its President. He has developed other medical devices that resulted in successful start-up ventures. B.S., Phi Beta Kappa, and , University of Illinois. Cardiology Fellowship, former Assistant Professor of Medicine and Director of the Adult Echocardiography Laboratory, Oregon Health Sciences University

Scott Corbett
Chief Technology Officer
Scott C......

Scott C...... has over 30 years experience as a biomedical engineer/executive in the medical device industry and co-founded two Seattle-based biomedical companies, MicroConnex and Advanced Cochlear Systems. He has held senior engineering/management positions at Precision Interconnect (now Tyco Healthcare), and GE Medical Ultrasound Division. B.S. Physics, Occidental College, M.S. Acoustics, Pennsylvania State University.

Elizabeth Ettling
Chief Financial Officer
Elizabeth E......

Ms. E...... has served on the management teams for three rapidly growing start up enterprises in the Portland area. Her experience includes building corporate infrastructure, human resource management, corporate governance, finance, tax and operations. She has assisted in raising venture capital and was also integrally involved with two initial public offerings. BS, California State University Los Angeles, Business Administration.


Funding Goal $1,500,000
Funding Raised So Far $1,500,000
Funding Commitments $0
Funding Remaining $0
Funding Type Common Equity
Pre-Money Valuation
Investor Ownership
Interest / Dividend
Previous Funding



Sonivate Medical, Inc.

Portland, OR 97239, US

Top 10 Tips for Entrepreneurs Seeking Funding

Users who follow these tips increase their fundraising odds substantially.

  • Complete Your Funding Profile
    • Complete your funding profile with all sections filled, including your products and services, a complete management team with headshots, and slideshow with product images.
  • Complete a Business Plan (Optional)
    • Complete a Business Plan in EquityNet and refine your financial projections using the benchmarking alerts in the Business Plan Analysis report.
  • Upload Important Investment Documents
    • Upload and present any other important investment documents such as pitch decks, financial statements, and offering materials.
  • Use EquityNet Crowdcast
    • Use the EquityNet Crowdcast system to automatically email invitations to your contacts in order to build additional exposure for your company.
  • Construct Concise Introductory Messages
    • Construct and send a concise introductory message to investors, including primary reasons why they should want to invest such as KPIs, expected returns, and forecasted revenue.
  • Be Proactive in Messaging Investors
    • Be proactive in messaging many investors and include a simple way for them to connect with you for a web meeting or call, such as a Calendly link.
  • Use the Activity System
    • Use the Activity system to track interested investors, and send prompt follow-up messages to investors who viewed your profile or showed interest.
  • Prepare for Due Diligence
    • Prepare for due diligence questions by interested investors and use your Business Plan and investment documents to satisfy such requests.
  • Keep Your Funding Profile Updated
    • Keep your funding profile updated with new funding raised/committed and message interested investors with any new milestones achieved.
  • Do Not Respond to Unknown Investors
    • Do not respond to or engage any parties outside of EquityNet that are not listed as approved investors (this may happen due to your public profile and LinkedIn connections).